These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23482991)

  • 1. Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy.
    Kevelam SH; Bugiani M; Salomons GS; Feigenbaum A; Blaser S; Prasad C; Häberle J; Baric I; Bakker IM; Postma NL; Kanhai WA; Wolf NI; Abbink TE; Waisfisz Q; Heutink P; van der Knaap MS
    Brain; 2013 May; 136(Pt 5):1534-43. PubMed ID: 23482991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome.
    Gerards M; Kamps R; van Oevelen J; Boesten I; Jongen E; de Koning B; Scholte HR; de Angst I; Schoonderwoerd K; Sefiani A; Ratbi I; Coppieters W; Karim L; de Coo R; van den Bosch B; Smeets H
    Brain; 2013 Mar; 136(Pt 3):882-90. PubMed ID: 23423671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
    Haack TB; Klee D; Strom TM; Mayatepek E; Meitinger T; Prokisch H; Distelmaier F
    Brain; 2014 Sep; 137(Pt 9):e295. PubMed ID: 24878502
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
    van der Knaap MS; Kevelam SH
    Brain; 2014 Sep; 137(Pt 9):e297. PubMed ID: 24878500
    [No Abstract]   [Full Text] [Related]  

  • 5. Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?
    Kamaşak T; Havalı C; İnce H; Eyüboğlu İ; Çebi AH; Sahin S; Cansu A; Aydin K
    Eur J Paediatr Neurol; 2018 Nov; 22(6):1139-1149. PubMed ID: 30054086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment.
    Algahtani H; Ghamdi S; Shirah B; Alharbi B; Algahtani R; Bazaid A
    Neurol Res; 2017 Feb; 39(2):117-125. PubMed ID: 27905264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy.
    Flønes I; Sztromwasser P; Haugarvoll K; Dölle C; Lykouri M; Schwarzlmüller T; Jonassen I; Miletic H; Johansson S; Knappskog PM; Bindoff LA; Tzoulis C
    PLoS One; 2016; 11(2):e0149055. PubMed ID: 26863430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eleven novel mutations and clinical characteristics in seven Chinese patients with thiamine metabolism dysfunction syndrome.
    Li D; Song J; Li X; Liu Y; Dong H; Kang L; Liu Y; Zhang Y; Jin Y; Guan H; Zhou C; Yang Y
    Eur J Med Genet; 2020 Oct; 63(10):104003. PubMed ID: 32679198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic spectrum of eleven patients and five novel MTFMT mutations identified by exome sequencing and candidate gene screening.
    Haack TB; Gorza M; Danhauser K; Mayr JA; Haberberger B; Wieland T; Kremer L; Strecker V; Graf E; Memari Y; Ahting U; Kopajtich R; Wortmann SB; Rodenburg RJ; Kotzaeridou U; Hoffmann GF; Sperl W; Wittig I; Wilichowski E; Schottmann G; Schuelke M; Plecko B; Stephani U; Strom TM; Meitinger T; Prokisch H; Freisinger P
    Mol Genet Metab; 2014 Mar; 111(3):342-352. PubMed ID: 24461907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association analysis identifies a mutation in the thiamine transporter 2 (SLC19A3) gene associated with Alaskan Husky encephalopathy.
    Vernau KM; Runstadler JA; Brown EA; Cameron JM; Huson HJ; Higgins RJ; Ackerley C; Sturges BK; Dickinson PJ; Puschner B; Giulivi C; Shelton GD; Robinson BH; DiMauro S; Bollen AW; Bannasch DL
    PLoS One; 2013; 8(3):e57195. PubMed ID: 23469184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency.
    Pérez-Dueñas B; Serrano M; Rebollo M; Muchart J; Gargallo E; Dupuits C; Artuch R
    Pediatrics; 2013 May; 131(5):e1670-5. PubMed ID: 23589815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis by whole exome sequencing of atypical infantile onset Alexander disease masquerading as a mitochondrial disorder.
    Nishri D; Edvardson S; Lev D; Leshinsky-Silver E; Ben-Sira L; Henneke M; Lerman-Sagie T; Blumkin L
    Eur J Paediatr Neurol; 2014 Jul; 18(4):495-501. PubMed ID: 24742911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome.
    Ortigoza-Escobar JD; Molero-Luis M; Arias A; Oyarzabal A; Darín N; Serrano M; Garcia-Cazorla A; Tondo M; Hernández M; Garcia-Villoria J; Casado M; Gort L; Mayr JA; Rodríguez-Pombo P; Ribes A; Artuch R; Pérez-Dueñas B
    Brain; 2016 Jan; 139(Pt 1):31-8. PubMed ID: 26657515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NARP-MILS syndrome caused by 8993 T>G mitochondrial DNA mutation: a clinical, genetic and neuropathological study.
    Rojo A; Campos Y; Sánchez JM; Bonaventura I; Aguilar M; García A; González L; Rey MJ; Arenas J; Olivé M; Ferrer I
    Acta Neuropathol; 2006 Jun; 111(6):610-6. PubMed ID: 16525806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-induced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease.
    Schänzer A; Döring B; Ondrouschek M; Goos S; Garvalov BK; Geyer J; Acker T; Neubauer B; Hahn A
    Brain Pathol; 2014 Apr; 24(3):270-9. PubMed ID: 24372704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerase gamma deficiency (POLG): clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh's encephalopathy.
    Scalais E; Francois B; Schlesser P; Stevens R; Nuttin C; Martin JJ; Van Coster R; Seneca S; Roels F; Van Goethem G; Löfgren A; De Meirleir L
    Eur J Paediatr Neurol; 2012 Sep; 16(5):542-8. PubMed ID: 22342071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.
    Gerards M; de Coo R; Smeets H
    Brain; 2014 Sep; 137(Pt 9):e296. PubMed ID: 24878501
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and laboratory survey of 65 Chinese patients with Leigh syndrome.
    Yang YL; Sun F; Zhang Y; Qian N; Yuan Y; Wang ZX; Qi Y; Xiao JX; Wang XY; Qi ZY; Zhang YH; Jiang YW; Bao XH; Qin J; Wu XR
    Chin Med J (Engl); 2006 Mar; 119(5):373-7. PubMed ID: 16542579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study.
    Depienne C; Bugiani M; Dupuits C; Galanaud D; Touitou V; Postma N; van Berkel C; Polder E; Tollard E; Darios F; Brice A; de Die-Smulders CE; Vles JS; Vanderver A; Uziel G; Yalcinkaya C; Frints SG; Kalscheuer VM; Klooster J; Kamermans M; Abbink TE; Wolf NI; Sedel F; van der Knaap MS
    Lancet Neurol; 2013 Jul; 12(7):659-68. PubMed ID: 23707145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leigh's disease due to a new mutation in the PDHX gene.
    Schiff M; Miné M; Brivet M; Marsac C; Elmaleh-Bergés M; Evrard P; Ogier de Baulny H
    Ann Neurol; 2006 Apr; 59(4):709-14. PubMed ID: 16566017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.